SCH-58500
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SCH-58500, covering 2015-04-16 to 2016-02-04. Get the full timeline:
Most recent: Clinical Trial Update: SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084) [Phase 1]